Chimera Investment (CIM) Gets a Sell Rating from Barclays
Barclays analyst Mark Devries maintained a Sell rating on Chimera Investment (CIM โ Research Report) on July 15 and set a price target of $9.00. The companys shares closed last Friday at $9.11, close to its 52-week low of $7.72.
According to TipRanks.com, Devries is a 5-star analyst with an average return of 12.8% and a 59.0% success rate. Devries covers the Financial sector, focusing on stocks such as Discover Financial Services, Fidelity National Financial, and First American Financial.
Currently, the analyst consensus on Chimera Investment is a Hold with an average price target of $10.00.
See Insidersโ Hot Stocks on TipRanks >> Chimera Investments market cap is currently $2.16B and has a P/E ratio of 12.79. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Chimera Investment Corp. operates as a real estate investment trust. It engages in investing directly or indirectly through its subsidiaries, on a leveraged basis, in a portfolio of mortgage assets. It includes residential mortgage loans, residential mortgage-backed securities, commercial mortgage loans, real estate-related securities, and various other asset classes. The company was founded on June 1, 2007 and is headquartered in New York, NY. Read More on CIM:- Morgan Stanley Remains a Buy on Breville Group Limited (BVILF)
- Zai Lab Announces Inclusion of its Ordinary Shares in Two Stock Connect Programs
- Forget Apple: Here Are 2 Lesser-Known Artificial Intelligence Stocks to Watch
- Morgan Stanley Reaffirms Their Buy Rating on Treasury Wine Estates Limited (TSRYF)
- Citigroup Thinks Simsโ Stock is Going to Recover
Paid Post: Content produced by TipRanks. The Globe and Mail was not involved, and material was not reviewed prior to publication.